This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (62)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Quality of Care  • Evidence-Based Medicine  • Review  • Alert me on articles by topic  Social Bookmarking   What's this?

A Meta-analysis of Randomized Controlled Trials

Akshay S. Desai, MD, MPH; James C. Fang, MD; William H. Maisel, MD, MPH; Kenneth L. Baughman, MD

JAMA. 2004;292:2874-2879.

Context  Implantable cardioverter defibrillator (ICD) therapy is effective in primary and secondary prevention of sudden cardiac death among patients with prior myocardial infarction and depressed ejection fraction. However, conclusive evidence of survival benefit in patients with nonischemic cardiomyopathy (NICM) is still lacking.

Objective  To determine whether ICD therapy reduces all-cause mortality in patients with NICM.

Data Sources  MEDLINE (1966-2004), EMBASE (1991-2004), the Cochrane Central Register of Controlled Trials (through first quarter, 2004), reports presented at scientific meetings (2003-2004), and bibliographic review of secondary sources. Search terms included defibrillator, randomized controlled trials, clinical trials, andsudden death.

Study Selection  Eligible studies were prospective randomized controlled trials of ICD or combined cardiac resynchronization therapy and defibrillator (CRT-D) vs medical therapy enrolling at least some individuals with NICM and reporting all-cause mortality as an outcome. Of 675 potentially relevant articles screened initially, 8 reports of randomized trials enrolling a total of 2146 patients with NICM were included.

Data Extraction  Included studies were reviewed to determine the number of patients randomized, mean duration of follow-up, primary end point, mortality of ICD cohort, and mortality of control cohort.

Data Synthesis  Five primary prevention trials enrolling 1854 patients with NICM were identified; pooled analysis suggested a significant reduction in total mortality among patients randomized to ICD or CRT-D vs medical therapy (risk ratio [RR], 0.69; 95% confidence interval [CI], 0.55-0.87; P = .002). Mortality reduction remained significant even after elimination of CRT-D trials. Two of the 3 secondary prevention trials presented subgroup estimates for ICD efficacy in NICM. Pooled analysis of these secondary prevention trials (n = 256 patients with NICM) indicated an equivalent but nonsignificant mortality reduction with ICD therapy (RR, 0.69; 95% CI, 0.39-1.24; P = .22). Analysis of all 7 trials combined demonstrated a statistically significant 31% overall reduction in mortality with ICD therapy (RR, 0.69; 95% CI, 0.56-0.86; P = .002).

Conclusion  ICD therapy appears to significantly reduce mortality in selected patients with NICM.

Author Affiliations: Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Cardiomyopathy
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2004;292(23):2936.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cardiac resynchronisation therapy for chronic heart failure and conduction delay
Cubbon and Witte
BMJ 2009;338:b1265-b1265.
FULL TEXT  

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
Hunt et al.
J Am Coll Cardiol 2009;53:e1-e90.
FULL TEXT  

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
2005 WRITING COMMITTEE MEMBERS et al.
Circulation 2009;119:e391-e479.
FULL TEXT  

Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation?
Plummer
Europace 2009;11:273-275.
FULL TEXT  

Ventricular Tachycardia and Sudden Cardiac Death
Koplan and Stevenson
Mayo Clin Proc. 2009;84:289-297.
ABSTRACT | FULL TEXT  

Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?: Implantable Cardioverter Defibrillator Implantation Guidelines Based Solely on Left Ventricular Ejection Fraction Do Not Apply to Adults With Congenital Heart Disease
Triedman
Circ Arrhythmia Electrophysiol 2008;1:307-316.
FULL TEXT  

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Authors/Task Force Members et al.
Eur Heart J 2008;29:2388-2442.
FULL TEXT  

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Dickstein et al.
Eur J Heart Fail 2008;10:933-989.
FULL TEXT  

Primary prevention of sudden cardiac death using implantable cardioverter defibrillators
Ding et al.
Europace 2008;10:1034-1041.
ABSTRACT | FULL TEXT  

Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot
Witte et al.
Europace 2008;10:926-930.
ABSTRACT | FULL TEXT  

Letter by Witte et al Regarding Article, "Implantable Cardioverter-Defibrillators in Tetralogy of Fallot"
Witte et al.
Circulation 2008;118:e99-e99.
FULL TEXT  

Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
Wu et al.
J Am Coll Cardiol 2008;51:2414-2421.
ABSTRACT | FULL TEXT  

Automatic home monitoring of implantable cardioverter defibrillators
Nielsen et al.
Europace 2008;10:729-735.
ABSTRACT | FULL TEXT  

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
J Am Coll Cardiol 2008;51:e1-e62.
FULL TEXT  

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
J Am Coll Cardiol 2008;51:2085-2105.
FULL TEXT  

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
Circulation 2008;117:2820-2840.
FULL TEXT  

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
Circulation 2008;117:e350-e408.
FULL TEXT  

Long-term Effects of Implanted Cardioverter-Defibrillators on Health Status, Quality of Life, and Psychological State
Carroll and Hamilton
Am J Crit Care 2008;17:222-230.
ABSTRACT | FULL TEXT  

Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy: A Competing Risk Study
Koller et al.
Circulation 2008;117:1918-1926.
ABSTRACT | FULL TEXT  

The fight against sudden cardiac death: consensus guidelines as a reference
Rossenbacker et al.
Eur Heart J Suppl 2007;9:I50-I58.
ABSTRACT | FULL TEXT  

Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials
Lam and Owen
BMJ 2007;335:925-925.
ABSTRACT | FULL TEXT  

Sudden Death Prevention With Implantable Devices
Passman and Kadish
Circulation 2007;116:561-571.
FULL TEXT  

The cost of implantable defibrillators: perceptions and reality
Camm et al.
Eur Heart J 2007;28:392-397.
ABSTRACT | FULL TEXT  

Primary prevention of sudden cardiac death
Kirchhof et al.
Heart 2006;92:1873-1878.
FULL TEXT  

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
Developed in Collaboration With the European Heart et al.
J Am Coll Cardiol 2006;48:e247-e346.
FULL TEXT  

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Writing Committee Members et al.
Europace 2006;8:746-837.
FULL TEXT  

Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold: The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial
Hohnloser et al.
Circulation 2006;114:104-109.
ABSTRACT | FULL TEXT  

Lessons learned from neutral ICD trials
Nisam and Breithardt
Europace 2006;8:393-397.
ABSTRACT | FULL TEXT  

What does the future hold for the management of chronic heart failure?
Vanoli and Adamson
Eur Heart J Suppl 2006;8:C51-C57.
ABSTRACT | FULL TEXT  

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure)
Developed in Collaboration With the American Colle et al.
J Am Coll Cardiol 2005;46:1116-1143.
FULL TEXT  

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society
Hunt et al.
Circulation 2005;112:1825-1852.
FULL TEXT  

Cardiac-Resynchronization Therapy in Heart Failure
Kirkorian et al.
NEJM 2005;353:205-206.
FULL TEXT  

Psychosocial Issues of Patients With Implantable Cardioverter Defibrillators
Dunbar
Am J Crit Care 2005;14:294-303.
ABSTRACT | FULL TEXT  

ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med. 2005;10:94-94.
FULL TEXT  

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2005;26:1115-1140.
FULL TEXT  

The Ethics of Deactivating Implanted Cardioverter Defibrillators
Berger
ANN INTERN MED 2005;142:631-634.
ABSTRACT | FULL TEXT  

JournalScan
Malik
Heart 2005;91:414-416.
FULL TEXT  

ICDs May Decrease Mortality in Patients with Nonischemic Cardiomyopathy
JWatch Emergency Med. 2005;2005:3-3.
FULL TEXT